Article Details
Retrieved on: 2021-07-14 07:35:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Medpace (NASDAQ:MEDP)'s stock had its "buy" rating reissued by stock analysts at Truist Securities in a research report issued on Tuesday, Stock ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here